Abstract
Compared with bare metal stents, drug-eluting stents (DES) reduce major adverse cardiac events (MACE) in the first year after PCI, but still have an ongoing 2%–3% annual event rate. The DynamX Coronary Bioadaptor is a 71 μm cobalt-chromium platform with a novel “uncaging” mechanism of circumferential rings, which maintains the axial links between the rings following uncaging. Unlike conventional metallic DES, this allows positive adaptive remodelling and restoration of vascular compliance and geometry, with potential long-term benefits.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
